[PDF][PDF] Postoperative acute pancreatitis after pancreatoduodenectomy: the importance of considering modifiers when validating a definition

S Connor - BJS open, 2022 - academic.oup.com
Postoperative acute pancreatitis (POAP) has become a point of interest among pancreatic
surgeons with the increasing recognition of its aetiological role in major postoperative …

Health-related quality of life after pancreatectomy: results from a randomized controlled trial

AA Eaton, M Gonen, P Karanicolas… - Annals of surgical …, 2016 - Springer
Background A recent prospective randomized trial demonstrated that prophylactic
pasireotide reduces the incidence of pancreatic complications (PC) after resection. This …

[HTML][HTML] Effects of ketorolac on complications and postoperative pancreatic fistula in patients undergoing pancreatectomy

S Sueda, A Adkins, A Dehal, M Al-Temimi, LH Chen… - HPB, 2023 - Elsevier
Background There are conflicting data on the risk of postoperative pancreatic fistula (POPF)
associated with postoperative NSAID use. The primary objective of this multi-center …

[HTML][HTML] Non-Surgical Interventions for the Prevention of Clinically Relevant Postoperative Pancreatic Fistula—A Narrative Review

N Rykina-Tameeva, JS Samra, S Sahni, A Mittal - Cancers, 2023 - mdpi.com
Simple Summary Clinically relevant postoperative pancreatic fistula (CR-POPF) continues to
be the leading cause of morbidity and mortality after pancreatic surgery. Attempts to prevent …

The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double …

MG Sarr, TPS Group - Journal of the American College of Surgeons, 2003 - Elsevier
BACKGROUND: Pancreatectomy can be complicated by pancreatic anastomotic leakage,
causing major morbidity. STUDY DESIGN: Our aim was to determine if vapreotide, a potent …

Pasireotide for the prevention of pancreatic fistula following pancreaticoduodenectomy: a cost-effectiveness analysis

N Goyert, G Eeson, DJ Kagedan, R Behman… - Annals of …, 2017 - journals.lww.com
Objective: To determine the cost-effectiveness of perioperative administration of pasireotide
for reduction of pancreatic fistula (PF). Summary: PF is a major complication following …

Randomized, placebo-controlled study of the efficacy of preoperative somatostatin administration in the prevention of postoperative complications following …

W Wang, B Tian, SR Babu, Y Zhang… - Hepato …, 2013 - europepmc.org
Results The incidences of POPF did not show a significant difference between the 2 groups
(11/30, 36.7% vs. 14/30, 46.7%; p> 0.385). However, blood transfusion volume was …

Somatostatin Analogues for Prevention of POPF: Better, Same, or Worse

PJ Allen - Annals of Surgery, 2024 - journals.lww.com
In the field of pancreatic surgery, the only practice subjected to more enduring dogmatic
opinion than the use of operative drains is whether or not somatostatin analogues should be …

Complications of pancreatic cancer resection

CM Halloran, P Ghaneh, L Bosonnet, MN Hartley… - Digestive …, 2002 - karger.com
Pancreatic cancer is a common cause of cancer death in the developed world. Currently,
resection is the only chance of long-term survival. The post-operative mortality in …

Selective perioperative administration of pasireotide is more cost-effective than routine administration for pancreatic fistula prophylaxis

JW Denbo, RS Slack, M Bruno, JM Cloyd… - Journal of …, 2017 - Elsevier
Background In a randomized trial, pasireotide significantly decreased the incidence and
severity of postoperative pancreatic fistula (POPF). Subsequent analyses concluded that its …